You need to enable JavaScript to run this app.
FDA reprimands two firms for missing validation programs, poor facility maintenance
Regulatory News
Joanne S. Eglovitch
Audit/inspection
North America
OTC
Pharmaceuticals
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionNorth AmericaOTCPharmaceuticalsRegulatory NewsJoanne S. EglovitchAudit/inspectionNorth AmericaOTCPharmaceuticals